Skip to main content
Clinical Trials/DRKS00015874
DRKS00015874Not yet recruitingPhase 4

Reduction of ventilation invasiveness through combined organ support - ADVOVENT (Advanced organ support for reduction of ventilation invasiveness)

niversitätsklinikum Schleswig-Holstein0 sites10 target enrollmentStarted: November 13, 2018Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • invasive controlled ventilation at acute hypercapnic respiratory failure (PaCO2 > 45 mmHg)
  • - tidal volume > 6ml/kg ideal weight or driving pressure difference (delta p) > 15 cmH2O required to reach a pH value > 7,30
  • - acute renal failure (KDIGO II or III)
  • - clinical indication for continuous venovenous haemodialysis
  • - consent to participate in the clinical trial

Exclusion Criteria

  • - severe acute hypoxemic respiratory failure (PaO2/FiO2 ratio < 100 mmHg)
  • - moribund status (clinical evaluation)
  • - gravidity
  • - severe haemodynamic instability (heart rate < 40 bpm or > 150 bpm or mean arterial pressure < 65 mmHg or cardiac output < 5 l/min despite adequate therapy)
  • - elevated intracranial pressure

Investigators

Sponsor
niversitätsklinikum Schleswig-Holstein

Similar Trials

Reduction of ventilation invasiveness... | Clinical Trial